Highlights Mesoblast placed its shares in a trading halt today. The company announced that it would undertake a private placement to raise capital. No further details were...
By Oliver Gray Investing.com - The ASX 200 was 67.60 points or 0.91% higher at 7,457.70 in Wednesday’s mid-morning deals, with market participants tracking an overnight rally on...
By Oliver Gray Investing.com - The S&P/ASX 200 finished Tuesday's session just 0.01% lower at 7378.4 after gains of 0.3% in the previous session, with the consumer staples sector...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
By Greg Peel Next week in the US is punctuated with the Thanksgiving holiday on the Thursday and an early close on Wall Street on the Friday. That Friday is “Black”,...
Mesoblast Limited is an Australia-based company that is engaged in the development of regenerative medicine products. The Company’s primary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It has applied its mesenchymal lineage cell technology platform to the allogeneic cellular medicines portfolio in the industry. Its technology addresses multiple inflammatory conditions with unmet medical needs. The Company’s portfolio of Phase III product candidates comprises remestemcel-L for steroid-refractory acute graft versus host disease (acute GVHD), as well as for the treatment of moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection, Revascor for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. The Company’s subsidiaries include Mesoblast, Inc., Mesoblast International Sarl, Mesoblast Australia Pty Ltd, Mesoblast UK Ltd and BeiCell Ltd.
| Average | 2.385 (+149.749% Upside) |
| High | 6.000 |
| Low | 0.9056 |
| Price | 0.955 |
| No. of Analysts | 4 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Neutral | Buy | Sell |
| Technical Indicators | Sell | Sell | Buy | Strong Buy | Strong Sell |
| Summary | Strong Sell | Sell | Neutral | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.31 | 2.34 | 2.29 | +0.01 | +0.43% | 8.37M | Sydney | |||
| 1.90 | 1.91 | 1.89 | 0.00 | 0.00% | 71.02K | Sydney | |||
| 2.97 | 2.975 | 2.935 | +0.010 | +0.34% | 1.22M | Sydney | |||
| 293.00 | 296.25 | 292.55 | -1.70 | -0.58% | 449.13K | Sydney | |||
| 1.52 | 1.55 | 1.51 | -0.04 | -2.25% | 2.30M | Sydney | |||
| 0.505 | 0.515 | 0.50 | -0.005 | -0.98% | 1.02M | Sydney | |||
| 0.61 | 0.62 | 0.61 | 0.00 | 0.00% | 6.24K | Sydney | |||
| 0.86 | 0.88 | 0.85 | -0.015 | -1.71% | 758.30K | Sydney | |||
| 60.59 | 61.60 | 58.74 | +3.01 | +5.23% | 529.90K | Sydney | |||
| 0.29 | 0.295 | 0.28 | +0.010 | +3.57% | 1.83M | Sydney | |||
| 28.36 | 28.50 | 28.18 | -0.13 | -0.46% | 141.82K | Sydney | |||
| 0.009 | 0.009 | 0.009 | +0.001 | +12.50% | 137.78K | Sydney | |||
| 66.61 | 67.33 | 66.20 | -0.08 | -0.12% | 320.75K | Sydney | |||
| 3.20 | 3.47 | 3.08 | -0.220 | -6.43% | 820.16K | Sydney | |||
| 31.83 | 31.88 | 31.665 | +0.040 | +0.13% | 3.03M | Sydney |